Skip to content

BioLife Solutions BLFS Other Financing

Other Financing at other companies

Danaher logo
DanaherDHR
-$28M-233%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$0-100%
Baxter International logo
Baxter InternationalBAX
-$14M+41.7%
Artivion logo
ArtivionAORT
-$210K-18.0%
Labcorp Holdings logo
Labcorp HoldingsLH
-$3.4M-3.0%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's other financing?
BioLife Solutions (BLFS) reported other financing of $3K in Q1 2026.
How has BioLife Solutions's other financing changed year-over-year?
BioLife Solutions's other financing decreased by 70.0% year-over-year, from $10K to $3K.
What is the long-term trend for BioLife Solutions's other financing?
Over 2 years (2021 to 2025), BioLife Solutions's other financing has grown at a -48.2% compound annual growth rate (CAGR), from -$123K to $33K.
What does other financing mean?
Miscellaneous financing cash flows not classified in specific line items.